PRKN and Alzheimer disease: Consistently, Parkin overexpression attenuates Aβ-induced fragmentation and mitochondrial dysfunction, as demonstrated by increased membrane potential (Δψm), ETC complex activity and ATP level, as well as decreased ROS production [110], thereby alleviating the toxic insults due to mitochondrial impairment associated with AD.